7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
FEDERAL MOGU FDML
5.47%
RADIANT LOGI RLGT
4.26%
ORBOTECH LTD ORBK
3.31%
NATUS MEDICA BABY
3.30%
NEW ORIENTAL EDU
2.95%

OMNOVA Solutions

by Bill Wilton

July 06, 2010 | Comments : 0 Recommended this article: (0)
OMN

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

OMNOVA Solutions Inc. ( OMN - Snapshot Report ) just posted a record-setting quarter to mark the sixth consecutive earnings surprise. Estimates continue to climb leaving OMN with a Zacks #1 Rank (Strong Buy).

Company Description

OMNOVA Solutions makes emulsion polymers and other specialty chemicals that have decorative and functional uses. The company serves commercial, industrial and residential markets.

Record Quarter

On Jun 29 OMNOVA reported quarterly results that showed net income of just over $15 million, triple the level one year ago. Earnings per share broke down to 29 cents, beating the Zacks Consensus Estimate by a dime.

The company saw a very nice 40% increase in sales, to $65 million, driven by higher pricing and more volume.

Estimates Climbing

Following the news, analysts revised their full-year estimates. OMNOVA is expected to earn 92 cents this year, up 8 cents. Next year's estimates are averaging 96 cents, a 3 cent improvement.

Given the 68 cents earned last year, the year-over-year growth rates are now 36% and 4%, respectively.

Valuation

Shares of OMN are trading at a nice discount. Currently you can own a piece of OMNOVA for less than 9 times forward earnings. The PEG ratio is a miniscule 0.2 times.

The Chart

Even with the great quarterly report, shares are still hitting resistance at this level. However, with momentum going the right way the stock has a good chance to break out and set a new 52-week high.

Read the April 1st Feature Here

OMNOVA Solutions - ticker OMN >
<P ALIGN=

Bill Wilton is the Growth Stock Strategist for Zacks.com. He is also the Editor in charge of the market-beating Zacks Growth Trader service

Last Week's Aggressive Growth Zacks Rank Buy Stocks

Local.com Corp (LOCM) raised its full-year outlook and analysts followed suit. Shares are trading at a nice multiple and at a good entry point. Read Full Article.

Medifast, Inc. (MED) analysts are raising estimates after a record setting quarter. The stock should see more investor attention after being added to a well known index. Read Full Article.

CarMax (KMX) was recently added to the S&P 500 after posting its seventh consecutive earnings surprise. Read Full Article.

Pier 1 Imports, Inc (PIR) analysts are raising estimates after the company posted a surprise profit last quarter. Shares are trading at a bargain and there is plenty of growth over the next few years. Read Full Article.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.